Omeprazole capsule

DRUG2 trials

Sponsors

Grünenthal GmbH, Eli Lilly and Company

Conditions

HealthyPharmacokinetic

Phase 1

Drug-drug Interaction Study to Evaluate the Effect of Omeprazole on CG5503 (Tapentadol)

CompletedNCT03979989

Grünenthal GmbHPharmacokinetic

Start: 2005-09-28End: 2005-11-16Updated: 2019-06-10

A Study of Effect of Multiple Doses of LOXO-305 on the Pharmacokinetics of Single Oral Doses of CYP1A2, CYP2C9, CYP2C19 Substrates in Healthy Participants

CompletedNCT06215430

Eli Lilly and CompanyHealthy

Start: 2021-01-11End: 2021-04-15Updated: 2025-03-10